Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Optibiotix Health to launch improved version of weight loss product Slimbiome

The new formulation is a single homogenous product, a development that reduces separation in transport
picture of tape measure
New version of Slimbiome will launch in Las Vegas at end of September

OptiBiotix Health plc (LON:OPTI) is to launch an improved version of its hunger suppressant/weight loss product Slimbiome at a major US trade fair at the end of the month.

The new formulation is a single homogenous product, a development that reduces separation in transport and makes it available in places such as in-store bakeries where previously it might have been difficult to blend or remix.

Solubility has also been improved, making it taste and fell better in existing products such as 'GoFigure' shakes and bars.

Improved dispersion in water will help open new markets, said Stephen O’Hara, chief executive as it makes it ideal for gym users who want to mix it into a liquid shake

The new formula will also be cheaper to produce as there is less waste.

Optibiotix already has US product registration for Slimbiome, which is a patented combination of natural ingredients, and will launch the new version at the Supply Side West trade show where it will be exhibited with Cereal Ingredients Inc, a potential joint development partner.

READ: OptiBiotix technology gaining commercial traction; more to come says broker

Cereal Ingredients is considering incorporating SlimBiome into a range of cereal based particulates and ingredients aimed at the nutraceutical, health and wellbeing sectors. 

Other manufacturers are looking at SlimBiome's possible application into 'Health & Wellbeing' food and beverage products.  

READ: OptiBiotix to hook-up with Bened Biomedical to open new routes into south-east Asia for its cholesterol reduction products

Optibiotix is also launching its LPLDL cholesterol and blood pressure lowering product at Supply Side West, which takes place in Las Vegas on 27-28 September. 

O'Hara added: "We have made significant progress in our transition from a research and development company to a commercial business, recently agreeing deals with Tata, Sacco and Nutrilinea; companies with high industry reputations and a global network of distribution partners.

“As we build the range of applications, products and geographic scope of SlimBiome with new manufacturing and distribution partners, the scale of the opportunity enlarges allowing us to fully exploit the revenue generating potential of our products.”

House broker finncap said the new formula was further evidence of the commercial progress the company is making, with the fact that talks with under way with other potential partners (to add to recent deals with Sacco and Tata Chemical) an encouraging development.

Shares rose 0.5% to 67.9p.

--Adds broker comment, detail and share price--

View full OPTI profile View Profile

OptiBiotix Health plc Timeline

Related Articles

ventripoint_device.png
June 21 2017
The device can give accurate and rapid volumetric information about all four chambers of the heart
1-Operation.jpg
January 18 2017
Deltex’s overseas sales are booming but its previously dominant NHS revenues are dropping off
1507647205_biotech_517925923.jpg
October 10 2017
Last month the group revealed its Barocycler 2320EXTREME device had been selected as a finalist in the prestigious R&D 100 Awards for 2017.

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use